MedTrace Logo

Use of a Brief Phone Call After ED Discharge

NCT01893931 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2003

Last updated 2016-07-11

No results posted yet for this study

Summary

The purpose of this study is to determine whether a phone call from a nurse within 1-3 days after discharge from the Emergency Department (ED) decreases return visits to the ED/ hospital admissions/ death (combined outcome) in patients age 65 and above. As secondary outcomes, time to follow up appointment with physician and economic impact of this intervention will be assessed.

Patients 65 years of age and older will be randomized following discharge from the ED into one of two groups. Group 1(Intervention) will receive a phone call collecting information about understanding of ED discharge instructions and guiding patient through the discharge instructions, and Group 2 (Placebo) will receive a follow up phone call for a satisfaction survey.

We hypothesize return visits to the ED and readmission to the hospital will decrease as a result of the nurse phone call intervention.

Conditions

  • Discharge Planning
  • Emergency Medicine
  • Geriatrics
  • Patient Readmission

Interventions

BEHAVIORAL

ED Discharge & Medication Call

Patients will receive a follow up phone call from a nurse to review discharge instructions and provide any necessary patient navigation.

BEHAVIORAL

Placebo Comparator

Sponsors & Collaborators

  • The William R. Kenan, Jr. Charitable Trust

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • John S Kizer, M.D. · University of North Carolina, Chapel Hill

  • Kevin Biese, M.D. · University of North Carolina, Chapel Hill

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01893931 on ClinicalTrials.gov